The collaboration with OSL, a leading regulated platform in Asia, marks MoneyHero's strategic expansion into the digital asset landscape, empowering users to make smarter and more informed financial decisions
The collaboration with OSL, a leading regulated platform in Asia, marks MoneyHero's strategic expansion into the digital asset landscape, empowering users to make smarter and more informed financial decisions
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the closing of its previously announced non-brokered private placement for gross proceeds of $4,905,150 - consisting of $3,555,150 of Units and $1,350,000 of Debenture Units (each as defined below).